Boston Scientific (BSX) - FREE Research Report

Mario Ernest who is Director at Boston Scientific sold 135,645 shares at $11.73 on Nov. 12, 2013. Following this transaction, the Director owned 394,959 shares meaning that the stake was reduced by 25.56% with the 135,645 share transaction.

Mirviss Jeffrey B. who is SVP&Pres, Periph Intervent at Boston Scientific sold 26,000 shares at $11.90 on Nov. 12, 2013. Following this transaction, the SVP&Pres, Periph Intervent owned 39,190 shares meaning that the stake was reduced by 39.88% with the 26,000 share transaction.

The shares most recently traded at $11.80, down $0.10, or 0.89% since the insider transaction. Historical insider transactions for Boston Scientific go as follows:

  • 4-Week # shares sold: 9,236
  • 12-Week # shares sold: 59,236
  • 24-Week # shares sold: 166,667

The average volume for Boston Scientific has been 14.4 million shares per day over the past 30 days. Boston Scientific has a market cap of $16.1 billion and is part of the health care sector and health services industry. Shares are up 110.3% year to date as of the close of trading on Tuesday.

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Currently there are 4 analysts that rate Boston Scientific a buy, no analysts rate it a sell, and 16 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BSX - FREE

TheStreet Quant Ratings rates Boston Scientific as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, compelling growth in net income, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Boston Scientific Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

5 Hated Stocks Poised for Big Short Squeezes

3 Stocks With Upcoming Ex-Dividend Dates: FMY, AWF, MNRO

Monro Muffler Brake (MNRO) Is Today's Dead Cat Bounce Stock

Monro Muffler (MNRO) Stock Sinks as Q4 Results, Guidance Miss Expectations

5 Hated Stocks You Should Love